Analyst Ratings for Mateon Therapeutics (MATN)

MATN Rating Summary

  |   Expand Research on MATN
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/7/2020 Litchfield Hills Theodore O'Neill New Coverage Buy
(N/A)		 3.00
(N/A)		 0.20
(0.26)		 30% Details
8/17/2018 H.C. Wainwright Joseph Pantginis Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.14
(0.26)		 85.71% Details